Figure 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
<p>Flow chart of study population. Note: Extending adjuvant hormone therapy was defined as continuing the therapy for ≥6 months and filling ≥2 prescriptions of tamoxifen or aromatase inhibitors beyond the 5-year adjuvant hormone therapy.</p>
Na minha lista:
| Autor principal: | Erwei Zeng (14958443) (author) |
|---|---|
| Outros Autores: | Wei He (14958446) (author), Arvid Sjölander (14958449) (author), Jenny Bergqvist (14958452) (author), Kamila Czene (14958455) (author) |
| Publicado em: |
2025
|
| Assuntos: | |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
Figure 2 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
por: Erwei Zeng (14958443)
Publicado em: (2025) -
Figure 3 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
por: Erwei Zeng (14958443)
Publicado em: (2025) -
Figure 4 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
por: Erwei Zeng (14958443)
Publicado em: (2025) -
Table 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
por: Erwei Zeng (14958443)
Publicado em: (2025) -
Figure 1 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
por: Alba L. Combita (22677298)
Publicado em: (2025)